Supplier profile
GlaxoSmithKline AS
Every public-sector award we hold for this supplier, across Norway, from 15 Feb 2014 to 28 Oct 2022.
Awards won
14
all time
Attributed value
€56.6m + NOK 328.4m
6 shared, unvalued
Buyers
2
public bodies
Active
2014–2022
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Folkehelseinstituttet | 12 | NOK 328.4m |
| Nasjonalt folkehelseinstitutt | 2 | €56.6m |
What they win
Awards
All 14 awards we hold
- Norway-Oslo: Vaccines ↗FolkehelseinstituttetNOK 80.0mawarded 28 Oct 2022
- Vaksine mot rotavirus ↗FolkehelseinstituttetNOK 1awarded 24 Oct 2022
- Norway-Oslo: Vaccines ↗FolkehelseinstituttetNOK 100.0mawarded 22 Jan 2021
- HPV-vaksine i barnevaksinasjonsprogrammet ↗Folkehelseinstituttetshared awardawarded 19 Jan 2021
- Norway-Oslo: Vaccines ↗FolkehelseinstituttetNOK 1awarded 29 Jul 2020
- Heksavalent vaksine - Kombinasjonsvaksine mot difteri, tetanus, kikhoste, polio, Hib og hepatitt B ↗Folkehelseinstituttetshared awardawarded 28 Jul 2020
- Norway-Oslo: Vaccines ↗FolkehelseinstituttetNOK 74.0mawarded 14 Dec 2018
- Rotavirusvaksine, ny kunngjøring ↗Folkehelseinstituttetshared awardawarded 13 Dec 2018
- Norway-Oslo: Pharmaceutical products ↗Folkehelseinstituttetshared awardawarded 9 Aug 2018
- Pandemisk influensavaksine ↗Folkehelseinstituttetshared awardawarded 8 Aug 2018
- Norway-Oslo: Vaccines ↗FolkehelseinstituttetNOK 74.4mawarded 29 Nov 2017
- Boostervaksine mot difteri, stivkrampe, kikhoste og polio til barnevaksinasjonsprogrammet (DTP-IPV) for 2. og 10.klasse ↗Folkehelseinstituttetshared awardawarded 28 Nov 2017
- Vaccines against pandemic influenza ↗Nasjonalt folkehelseinstitutt€55.4mawarded 7 Mar 2014
- Supply agreement for 2013 and 2014 with options for 2015 and 2016. ↗Nasjonalt folkehelseinstitutt€1.2mawarded 15 Feb 2014
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Glaxosmithkline542 awards · £2.2m
- GLAXOSMITHKLINE, S.A.971 awards
- GlaxoSmithKline Inc.493 awards
- GLAXOSMITHKLINE S.P.A.318 awards
- GLAXOSMITHKLINE, LLC309 awards
- GlaxoSmithKline, s.r.o.100 awards
- GlaxoSmithKline GmbH & Co. KG84 awards
- GlaxoSmithKline AB80 awards
- GlaxoSmithKline (GSK) SRL45 awards
- GlaxoSmithKline Oy31 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.